168 related articles for article (PubMed ID: 7597301)
1. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
2. [Elective lymph node dissection in primary malignant melanoma].
Petres J; Rompel R; Büttner P; Teichelmann K; Garbe C
Hautarzt; 1996 Jan; 47(1):29-34. PubMed ID: 8835001
[TBL] [Abstract][Full Text] [Related]
3. Elective lymph node dissection in primary malignant melanoma: a matched-pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Melanoma Res; 1995 Jun; 5(3):189-94. PubMed ID: 7640521
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of elective lymph node dissection in malignant melanoma of the extremities and trunk. An analysis in view of the sentinel lymph node biopsy].
Zimmermann T; Andresen S; Schmitt H; Padberg W
Zentralbl Chir; 2001 Apr; 126(4):279-82. PubMed ID: 11370389
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma.
McCarthy WH; Shaw HM; Milton GW
Surg Gynecol Obstet; 1985 Dec; 161(6):575-80. PubMed ID: 4071371
[TBL] [Abstract][Full Text] [Related]
8. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients.
Drepper H; Köhler CO; Bastian B; Breuninger H; Bröcker EB; Göhl J; Groth W; Hermanek P; Hohenberger W; Lippold A
Cancer; 1993 Aug; 72(3):741-9. PubMed ID: 8334626
[TBL] [Abstract][Full Text] [Related]
9. Elective lymph node dissection in stage I malignant melanoma: a meta-analysis.
Hein DW; Moy RL
Melanoma Res; 1992 Nov; 2(4):273-7. PubMed ID: 1490115
[TBL] [Abstract][Full Text] [Related]
10. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
11. Elective regional lymph node dissection in malignant melanoma.
Binder M; Pehamberger H; Steiner A; Wolff K
Eur J Cancer; 1990; 26(8):871-3. PubMed ID: 2145927
[TBL] [Abstract][Full Text] [Related]
12. Is there a relation between type of primary melanoma treatment and the development of intralymphatic metastasis? A review of the literature.
Sloot S; Speijers MJ; Bastiaannet E; Hoekstra HJ
Cancer Treat Rev; 2016 Apr; 45():120-8. PubMed ID: 27015564
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
14. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991.
Coates AS; Ingvar CI; Petersen-Schaefer K; Shaw HM; Milton GW; O'Brien CJ; Thompson JF; McCarthy WH
J Am Coll Surg; 1995 Apr; 180(4):402-9. PubMed ID: 7719543
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.
Balch CM; Soong S; Ross MI; Urist MM; Karakousis CP; Temple WJ; Mihm MC; Barnhill RL; Jewell WR; Wanebo HJ; Harrison R
Ann Surg Oncol; 2000 Mar; 7(2):87-97. PubMed ID: 10761786
[TBL] [Abstract][Full Text] [Related]
16. The impact of sentinel node dissection on disease-free and overall tumour-specific survival in melanoma patients: a single centre group-matched analysis of 1192 patients.
Geimer T; Sattler EC; Flaig MJ; Ruzicka T; Berking C; Schmid-Wendtner MH; Kunte C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):629-635. PubMed ID: 27556957
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
18. [Results of elective lymph node excision in melanoma of the trunk].
Zimmermann T; Buhr J; Kelm C; Padberg W
Zentralbl Chir; 1996; 121(6):478-82. PubMed ID: 8767335
[TBL] [Abstract][Full Text] [Related]
19. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
Shen P; Guenther JM; Wanek LA; Morton DL
Ann Surg Oncol; 2000 Mar; 7(2):114-9. PubMed ID: 10761789
[TBL] [Abstract][Full Text] [Related]
20. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
